SIGA Technologies, Inc. (SIGA) Insider Trading Activity
NASDAQ$5.93
Market Cap
$423.65M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
795 of 877
Rank in Industry
47 of 53
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
SIGA Insider Trading Activity
SIGA Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
About SIGA Technologies, Inc.
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Insider Activity of SIGA Technologies, Inc.
Over the last 12 months, insiders at SIGA Technologies, Inc. have bought $0 and sold $0 worth of SIGA Technologies, Inc. stock.
On average, over the past 5 years, insiders at SIGA Technologies, Inc. have bought $0 and sold $223,800 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $44,200 was made by Gomez Phillip Louis III () on 2019‑12‑09.
List of Insider Buy and Sell Transactions, SIGA Technologies, Inc.
| 2021-12-09 | Sale | Antal James | director | 30,000 0.0401% | $7.82 | $234,600 | +23.68% | |
| 2020-08-27 | Sale | Antal James | 30,000 0.0385% | $7.10 | $213,000 | -3.67% | ||
| 2019-12-09 | Gomez Phillip Louis III | 10,000 0.0125% | $4.42 | $44,200 | +35.42% | |||
| 2019-12-09 | SAVAS PAUL G | 20,000 0.0247% | $4.37 | $87,400 | +35.42% | |||
| 2019-12-09 | Luckshire Daniel J | 5,000 0.0062% | $4.39 | $21,950 | +35.42% | |||
| 2019-12-09 | Kane Julie | 2,500 0.0031% | $4.39 | $10,975 | +35.42% | |||
| 2019-08-23 | SAVAS PAUL G | 10,000 0.0124% | $4.95 | $49,500 | +9.14% | |||
| 2019-08-09 | SAVAS PAUL G | 10,000 0.0124% | $5.08 | $50,800 | +4.31% | |||
| 2019-06-07 | Sale | Hruby Dennis E | 16,000 0.0197% | $5.58 | $89,280 | -6.81% | ||
| 2019-06-06 | Sale | Hruby Dennis E | 17,000 0.0212% | $5.57 | $94,690 | -5.07% | ||
| 2019-06-05 | Sale | Hruby Dennis E | 17,000 0.0211% | $5.68 | $96,560 | -7.02% | ||
| 2019-06-05 | Sale | Antal James | 30,000 0.0374% | $5.70 | $171,000 | -7.02% | ||
| 2019-06-04 | BAYER MICHAEL J | 12,500 0.0152% | $5.74 | $71,750 | -9.86% | |||
| 2018-11-16 | SAVAS PAUL G | 5,000 0.0063% | $5.58 | $27,900 | +0.98% | |||
| 2018-11-13 | Sale | Hruby Dennis E | 31,099 0.0384% | $5.29 | $164,514 | +5.36% | ||
| 2018-11-12 | Sale | Hruby Dennis E | 18,901 0.0238% | $4.96 | $93,749 | +14.40% | ||
| 2018-11-12 | SAVAS PAUL G | 10,000 0.0127% | $5.01 | $50,100 | +14.40% | |||
| 2018-11-12 | Gomez Phillip Louis III | 15,000 0.0198% | $5.20 | $78,000 | +14.40% | |||
| 2015-09-24 | Sale | ROSE ERIC A MD | Chief Executive Officer | 20,000 0.0359% | $1.21 | $24,200 | -33.60% | |
| 2015-09-01 | Sale | ROSE ERIC A MD | Chief Executive Officer | 20,000 0.0368% | $1.32 | $26,400 | -37.59% |
Total: 101
Insider Historical Profitability
12.58%
| MacAndrews & Forbes Holdings Inc. | 13509722 18.9103% | $80.11M | 6 | 0 | <0.0001% | |
| ROSE ERIC A MD | Chief Executive Officer | 582897 0.8159% | $3.46M | 3 | 7 | +78.43% |
| KASTEN BERNARD L | Chief Executive Officer | 553559 0.7748% | $3.28M | 1 | 0 | <0.0001% |
| Gomez Phillip Louis III | 475782 0.666% | $2.82M | 2 | 0 | +24.91% | |
| BURGESS SUSAN K | 365783 0.512% | $2.17M | 0 | 7 | ||
| SAVAS PAUL G | 292847 0.4099% | $1.74M | 8 | 0 | +5.44% | |
| Luckshire Daniel J | 224943 0.3149% | $1.33M | 1 | 1 | +35.42% | |
| CONSTANCE THOMAS E | director | 155000 0.217% | $919,150.00 | 0 | 2 | |
| Hruby Dennis E | 147465 0.2064% | $874,467.45 | 0 | 13 | ||
| BAYER MICHAEL J | 132244 0.1851% | $784,206.92 | 3 | 3 | <0.0001% | |
| Antal James | director | 100875 0.1412% | $598,188.75 | 0 | 4 | |
| SLOVIN BRUCE | director | 95000 0.133% | $563,350.00 | 9 | 2 | +59.85% |
| Odden John | VP - Business Development | 55240 0.0773% | $327,573.20 | 4 | 0 | <0.0001% |
| Bevins William C | director | 50000 0.07% | $296,500.00 | 1 | 0 | +16.22% |
| Fasman Steven L | director | 47000 0.0658% | $278,710.00 | 1 | 0 | +25% |
| Marshall Joseph W III | director | 30000 0.042% | $177,900.00 | 3 | 0 | <0.0001% |
| TRANSTECH PHARMA INC | 10 percent owner | 20983 0.0294% | $124,429.19 | 0 | 2 | |
| MJALLI ADNAN M M | 20983 0.0294% | $124,429.19 | 0 | 2 | ||
| Kane Julie | 2500 0.0035% | $14,825.00 | 1 | 0 | +35.42% | |
| STERN ANDREW L | director | 2150 0.003% | $12,749.50 | 1 | 0 | <0.0001% |
| TOWNSEND FRANCES F | director | 2000 0.0028% | $11,860.00 | 1 | 0 | <0.0001% |
| WEINER MICHAEL MD | director | 0 0% | $0 | 0 | 11 | |
| PERELMAN RONALD O | 10 percent owner | 1 0% | $5.93 | 2 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$187,390,806 | 89 | 12.62% | $824.94M | |
$12,681,496 | 70 | 20.90% | $825.18M | |
$218,350,131 | 64 | 16.68% | $144.69M | |
$129,489,279 | 57 | 26.09% | $381.83M | |
SIGA Technologies, Inc. (SIGA) | $33,884,330 | 45 | 12.58% | $423.65M |
$97,642,477 | 41 | -10.58% | $644.11M | |
$11,542,910 | 40 | 56.19% | $922.08M | |
$6,021,989 | 30 | -0.17% | $220.51M | |
$6,506,230 | 27 | -16.20% | $793.96M | |
$17,389,773 | 25 | -6.03% | $348.43M | |
$1,507,654 | 22 | -23.16% | $95.4M | |
$25,034,841 | 20 | 9.38% | $105.02M | |
$758,061 | 9 | 60.03% | $138.03M | |
$26,633,903 | 9 | 42.23% | $933.09M | |
$1,683,154 | 8 | 46.59% | $445.45M | |
$179,515 | 7 | 1.51% | $306.13M | |
$543,932 | 6 | -22.03% | $677.35M | |
$514,533 | 5 | 29.61% | $946.87M | |
$5,003,136 | 1 | -14.58% | $246.96M |
SIGA Institutional Investors: Active Positions
| Increased Positions | 77 | +38.89% | 2M | +6.69% |
| Decreased Positions | 85 | -42.93% | 4M | -10.55% |
| New Positions | 23 | New | 348,780 | New |
| Sold Out Positions | 28 | Sold Out | 1M | Sold Out |
| Total Postitions | 190 | -4.04% | 34M | -3.86% |
SIGA Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $21,372.00 | 5.35% | 3.8M | -80,071 | -2.07% | 2025-03-31 |
| Altravue Capital, Llc | $14,861.00 | 3.72% | 2.64M | +326,630 | +14.12% | 2024-12-31 |
| Vanguard Group Inc | $13,977.00 | 3.5% | 2.48M | -83,589 | -3.26% | 2024-12-31 |
| First Wilshire Securities Management Inc | $13,368.00 | 3.34% | 2.37M | -64,293 | -2.64% | 2024-12-31 |
| Dimensional Fund Advisors Lp | $11,970.00 | 2.99% | 2.13M | +217,926 | +11.42% | 2024-12-31 |
| Hotchkis & Wiley Capital Management Llc | $11,627.00 | 2.91% | 2.07M | +16,800 | +0.82% | 2024-12-31 |
| American Century Companies Inc | $7,161.00 | 1.79% | 1.27M | +114,270 | +9.87% | 2024-12-31 |
| State Street Corp | $6,515.00 | 1.63% | 1.16M | +59,314 | +5.4% | 2024-12-31 |
| Geode Capital Management, Llc | $6,375.00 | 1.6% | 1.13M | +19,654 | +1.77% | 2024-12-31 |
| Citadel Advisors Llc | $5,922.00 | 1.48% | 1.05M | -16,668 | -1.56% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Price to Earnings
Price/Earnings to Growth
Price to Sales
Price to Book
Price/Free Cash Flow
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.